Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Allogene Therapeutics (ALLO) Other Gross PP&E Adjustments (2019 - 2025)

Allogene Therapeutics' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $104.5 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 23.16% year-over-year to $104.5 million; the TTM value through Sep 2025 reached $104.5 million, down 23.16%, while the annual FY2024 figure was $81.5 million, 32.53% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was $104.5 million at Allogene Therapeutics, up from $103.9 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $140.9 million in Q2 2024 and bottomed at $40.4 million in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $86.1 million (2024), against an average of $87.6 million.
  • The largest annual shift saw Other Gross PP&E Adjustments tumbled 45.13% in 2022 before it skyrocketed 101.04% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $73.6 million in 2021, then crashed by 45.13% to $40.4 million in 2022, then skyrocketed by 52.25% to $61.5 million in 2023, then soared by 32.53% to $81.5 million in 2024, then increased by 28.16% to $104.5 million in 2025.
  • Per Business Quant, the three most recent readings for ALLO's Other Gross PP&E Adjustments are $104.5 million (Q3 2025), $103.9 million (Q2 2025), and $104.6 million (Q1 2025).